Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
864
-4
-0.5% -$1.37K 0.22% 71
2026
Q1
$305K Hold
868
– – 0.24% 66
2025
Q4
$285K Sell
868
-60
-6% -$19K 0.23% 66
2025
Q3
$262K Sell
928
-50
-5% -$14.5K 0.21% 69
2025
Q2
$273K Buy
978
+25
+3% +$7.08K 0.23% 68
2025
Q1
$297K Hold
953
– – 0.28% 61
2024
Q4
$248K Buy
+953
New +$283K 0.22% 72

Other funds holding AMGN

PCG Asset Management's AMGN Position: Q2 2026 in Review

PCG Asset Management reduced its Amgen (AMGN) stake by 0.46% in Q2 2026, selling an estimated $1.37K and leaving 864 shares worth $313K. The position accounts for 0.22% of the portfolio, ranked #71.

PCG Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PCG Asset Management held 864 shares of Amgen worth $313K as of Q2 2026.
  • PCG Asset Management sold 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.22% of PCG Asset Management's portfolio in Q2 2026, its #71 holding.
  • PCG Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PCG Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.